Baker Brothers Advisors - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,584,385
-43.6%
2,006,4510.0%0.04%
-43.6%
Q2 2023$13,443,222
+2.9%
2,006,4510.0%0.08%
+9.9%
Q1 2023$13,061,996
-23.7%
2,006,4510.0%0.07%
-31.1%
Q4 2022$17,115,027
+132.7%
2,006,451
+742.7%
0.10%
+221.9%
Q2 2021$7,355,000
-29.2%
238,0950.0%0.03%
-28.9%
Q1 2021$10,388,000
-5.8%
238,0950.0%0.04%
+7.1%
Q4 2020$11,033,000238,0950.04%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders